Logan Lutton

The patient panels of physicians underrepresented in medicine (URiM) showed that they had greater odds of being a Medicaid provider than White family physicians.

Aqneursa is the second drug approved within a week to treat Niemann-Pick Disease, Type C.

The FDA has already approved Zoryve cream (0.3% and 0.15%) for plaque psoriasis and atopic dermatitis in adults and children ages 6 and up. Currently, Zoryve foam 0.3% is only approved to treat seborrheic dermatitis in adult and pediatric patients 9 years and older.

This is the first FDA approved medication for the rare and progressive neurodegenerative disease, Niemann-Pick Disease Type C.

Bimzelx was first approved last year for the treatment of moderate to severe psoriasis in adults, making it the first and only IL-17A and IL-17F inhibitor approved in the United States for four autoimmune diseases.

Here’s what you missed this week on Managed Healthcare Executive.

Today’s approval means that FluMist is the first pharmacy-prescribed influenza vaccine that does not need to be given by a healthcare professional.

Participants cite the recent, ongoing popularity of GLP-1 drugs prescribed for weight loss.

Independence Blue Cross has increased local provider options by 47% since 2022, and now offers additional mental health and substance abuse services.

More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.

Insulin resistance reduction was seen in trials using both estrogen and estrogen plus progesterone, a meta-analysis of 17 studies reveal.

This new, first-line biologic treatment provided symptom relief for patients for up to one year.

Kristi Funk, M.D., FACS, discusses the current outlook for breast cancer cases worldwide, underscoring its seriousness. “I think we have to understand everything is getting worse,” she said.

Here’s what you missed this week on Managed Healthcare Executive.

Out of the three stages of menopause, perimenopausal women living with HIV experience the worst COVID-19 symptoms, possibly due to increased inflammation.

When taken in combination with an ART regimen, metformin reduced the amount of HIV production and reduced inflammation by hindering production of the molecule that helps HIV multiply.

If approved, neffy would be the first new delivery method in more than 35 years for small children.

Insight into nocturnal hot flash timing could provide clues about heart disease risk in perimenopausal women.

Kristi Funk, M.D., FACS, medical director and co founder of the Pink Lotus Breast Center, describes why there is a lack of awareness surrounding the link between breast cancer and nutrition.

Women with disadvantaged backgrounds may also benefit more than women with a higher socioeconomic status, study results show.

Here's what you missed this week on Managed Healthcare Executive.

HIV treatments using a single pill improve adherence and are cheaper to maintain.

Joseph Shields of TransparencyRx predicts there will be more lawsuits against self-funded employers alleging they’ve mismanaged prescription drug benefits through PBMs.

During an interview, Joseph Shields of TransparencyRx discusses the PBM legislation that is expected to move forward in Congress in the next few months.

Breast cancer patients were also less likely to have a breast reconstruction than patients living elsewhere.

Sebetralstat would be the first oral, on-demand treatment for hereditary angioedema if approved.

Here’s what you missed this week on Managed Healthcare Executive.

Emergent BioSolutions is planning to donate 50,000 doses of the mpox vaccine to countries in Central Africa.

A new survey of Medicaid-eligible New England residents examines healthcare inequities in detail.

This latest grant is part of a larger $500 million CMS program designed to identify and support communities in need.